SCHEMBL2825232

SCHEMBL2825232

Nc1ccc2c(c1)OCCN2C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.45
MAPT P10636 4/20 0.40
KDM4E B2RXH2 2/20 0.40
GAA P10253 2/20 0.40
POLB P06746 1/20 0.40
KDR P35968 2/20 0.39
THRB P10828 2/20 0.39
MEN1 O00255 1/20 0.39
ALOX15 P16050 1/20 0.39
GFER P55789 1/20 0.39
YWHAG P61981 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD17B10 Q99714 1/20 0.39
HTT P42858 1/20 0.38
PDK1 Q15118 1/20 0.38
DGAT1 O75907 5/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
USP30 Q70CQ3 1/20 0.36
SOAT2 O75908 1/20 0.36
RORC P51449 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17965211 0.88 NOTUM (0.45) NOTUMMAPTKDM4EGAAPOLB
SCHEMBL24629925 0.86 NOTUM (0.63) NOTUMMAPTPOLBTHRBMEN1
SCHEMBL8131708 0.82 MAPT (0.45) NOTUMMAPTKDM4EPOLBKDR
SCHEMBL18568320 0.82 CA12 (0.43) NOTUMMAPTKDM4EGAAPOLB
SCHEMBL30132886 0.79 USP30 (0.50) NOTUMMAPTKDM4EKDRTHRB
SCHEMBL2825274 0.79 USP30 (0.50) NOTUMMAPTKDM4EKDRTHRB
SCHEMBL2060747 0.78 NOTUM (0.52) NOTUMMAPTKDM4EGAATHRB
SCHEMBL13521873 0.77 TP53 (0.40) NOTUMMAPTKDRTHRBMEN1
SCHEMBL4900405 0.77 SLC22A12 (0.49) NOTUMMAPTGAAPOLBPDK1
SCHEMBL6648039 0.77 NOTUM (0.73) NOTUMMAPTPOLBTHRBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230148299-A1 FEM1B PROTEIN BINDING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2023-05-11 US disclosed
EP-4117640-A1 FEM1B PROTEIN BINDING AGENTS AND USES THEREOF The Regents of the University of California (US) 2023-01-18 EP disclosed
WO-2021183431-A1 FEM1B PROTEIN BINDING AGENTS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2021-09-16 WO disclosed
EP-2226322-B1 IMIDAZOLE CARBONYL COMPOUND DAIICHI SANKYO CO LTD (JP) 2015-01-21 EP disclosed
US-8927588-B2 Imidazole carbonyl compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2015-01-06 US disclosed
US-20140073622-A1 IMIDAZOLE CARBONYL COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2014-03-13 US disclosed
US-8536197-B2 Imidazole carbonyl compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2013-09-17 US disclosed
US-20100311966-A1 IMIDAZOLE CARBONYL COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-12-09 US disclosed
EP-2226322-A1 IMIDAZOLE CARBONYL COMPOUND Daiichi Sankyo Company, Limited (JP) 2010-09-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230148299-A1 FEM1B PROTEIN BINDING AGENTS AND USES THEREOF FEM1B, GSKIP, FNIP1 NOTUM 4098/4885MAPT 2106/4885KDM4E 2287/4885
US-20100311966-A1 IMIDAZOLE CARBONYL COMPOUND TOP1, TOP2B, TOP2A NOTUM 2065/4885MAPT 1455/4885KDM4E 206/4885
US-20140073622-A1 IMIDAZOLE CARBONYL COMPOUND TOP1, TOP2B, TOP2A NOTUM 1110/4885MAPT 1979/4885KDM4E 211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.